Comments
Loading...
Avenue Therapeutics (ATXI) Forecast
NewsEarningsAvenue Therapeutics (ATXI) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAvenue Therapeutics (NASDAQ:ATXI) Stock Quotes, Forecast and News Summary
Avenue Therapeutics Stock (NASDAQ: ATXI) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Avenue Therapeutics (ATXI) stock?
You can purchase shares of Avenue Therapeutics (NASDAQ:ATXI) through any online brokerage.
Who are Avenue Therapeutics (ATXI) competitors?
Other companies in Avenue Therapeutics’s space includes: 60 Degrees (NASDAQ:SXTP), Kiora Pharmaceuticals (NASDAQ:KPRX), Sonoma Pharmaceuticals (NASDAQ:SNOA), Hepion Pharmaceuticals (NASDAQ:HEPA) and Redhill Biopharma (NASDAQ:RDHL).
What is the forecast, or price target, for Avenue Therapeutics (ATXI) stock?
Avenue Therapeutics has a consensus price target of $16.38.
What is the current price for Avenue Therapeutics (ATXI)?
The stock price for Avenue Therapeutics (NASDAQ: ATXI) is $1.7584 last updated December 24, 2024 at 10:51 AM EST.
Does Avenue Therapeutics (ATXI) pay a dividend?
There are no upcoming dividends for Avenue Therapeutics.
When is Avenue Therapeutics (NASDAQ:ATXI) reporting earnings?
Avenue Therapeutics’s Q4 earnings are confirmed for Monday, March 17, 2025.
Is Avenue Therapeutics (ATXI) going to split?
There is no upcoming split for Avenue Therapeutics.
What sector and industry does Avenue Therapeutics (ATXI) operate in?
Avenue Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.